IP Library Granted Patent US 9,828,599
Granted Patent B2
US 9,828,599 · App. 14/030,386 · Granted Nov 28, 2017

Methods of selecting binding-elements and uses thereof

Inventors: Nandini Nagraj (Clifton Park, NY); Radislav Alexandrovich Potyrailo (Niskayuna, NY); Andrew David Pris (Altamont, NY); John Richard Nelson (Clifton Park, NY)
Assignee: General Electric Company
C12N15/1034C12N15/1048C12Q1/6811G01N33/53G01N33/5308H04N1/3232H04N1/32309H04N1/32352H04N1/40H04N1/60C40B30/04H04N2201/0094H04N2201/327H04N2201/3233H04N2201/3271H04N2209/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,828,599
App. No.
14/030,386
Granted
Nov 28, 2017
Kind
B2
Abstract

Methods for selecting a binding-element are provided. The method comprised of different steps. A first mixture is formed using at least one target molecule and a plurality of oligomers, followed by incubating the first mixture to form a second mixture comprising at least one target-bound oligomer and at least one target-unbound oligomer. Then a first accelerator is added to cleave the target-unbound oligomer and the target-bound oligomer is separated from the target molecule. This is followed by addition of a second accelerator for ligation, and a third accelerator for amplification followed by sequencing and post sequence analysis to select the binding-element.

Claims (27)

1. A method of selecting a binding-element, comprising:

providing a first mixture comprising at least one target molecule and a plurality of oligonucleotides;

incubating the first mixture to form a second mixture comprising at least one target-bound oligonucleotide and at least one target-unbound oligonucleotide;

adding a first accelerator to the second mixture to cleave the target-unbound oligonucleotides;

separating the target-bound oligonucleotides from the target molecule forming target specific oligonucleotides;

adding a second accelerator to the target-specific oligonucleotides to ligate the target-specific oligonucleotides and form a target-specific circularized nucleic acid; and

adding a third accelerator to the target-specific circularized nucleic acid for amplifying the target-specific circularized nucleic acid by isothermal amplification to form a binding-element.

2. The method of claim 1 , wherein the first accelerator, the second accelerator, or the third accelerator comprises a biological molecule, a chemical molecule, an environmental condition or combinations thereof.

3. The method of claim 1 , wherein the first accelerator comprises an exo-nuclease, an endo-nuclease or a combination thereof.

4. The method of claim 1 , wherein the second accelerator comprises a ligase.

5. The method of claim 1 , wherein the third accelerator comprises a polymerase.

6. The method of claim 1 , wherein the oligonucleotides comprise non-complimentary end sequences.

7. The method of claim 6 , wherein the oligonucleotides comprise a random sequence.

8. The method of claim 7 , wherein the oligonucleotides further comprise a marker sequence at the one end.

9. The method of claim 1 , further comprising phosphorylating a 5′ end of the target-specific oligonucleotides before the step of adding the second accelerator.

10. The method of claim 1 , wherein the ligation is achieved by incubating the second accelerator and the target specific oligonucleotides between 0 to 37° C.

11. The method of claim 1 , wherein the ligation is achieved by incubating the second accelerator and the target specific oligonucleotides at 25° C.

12. The method of claim 1 , further comprising sequencing the binding-element to form a binding-element sequence.

13. The method of claim 12 , wherein the binding-element sequence comprises a recombination site.

14. The method of claim 12 , wherein the binding-element sequence is configured to determine the target molecule from a sample comprising the target molecule by affinity binding.

15. The method of claim 1 , wherein the oligonucleotides are modified to provide increased hydrophobicity.

16. The method of claim 1 , wherein the separation of the target-bound oligonucleotides is achieved by chemical precipitation comprising acid precipitation, ethanol precipitation, or combinations thereof.

17. The method of claim 1 , wherein the separation of the target-bound oligonucleotides is achieved by chromatographic technique, electrophoretic technique or a combination thereof.

18. The method of claim 17 , wherein the chromatographic technique comprises gel-filtration chromatography, ion-exchange chromatography, affinity chromatography or combinations thereof.

19. The method of claim 18 , wherein the electrophoretic technique comprises gel-electrophoresis.

20. The method of claim 1 , wherein the oligonucleotides bind to the target molecule by covalent interaction, ionic interaction, hydrogen bonding, Vander Waal's forces, multivalent binding, cooperative binding, charge-charge interactions, or combinations thereof.

21. The method of claim 1 , wherein the oligonucleotides comprise deoxyribonucleic acids, ribonucleic acids, peptide nucleic acids or combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2020
From: GENERAL ELECTRIC COMPANY
To: GLOBAL LIFE SCIENCES SOLUTIONS USA LLC
Reel/Frame 053966/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 18, 2013
From: NAGRAJ, NANDINI; POTYRAILO, RADISLAV ALEXANDROVICH; PRIS, ANDREW DAVID; NELSON, JOHN RICHARD
To: GENERAL ELECTRIC COMPANY
Reel/Frame 031232/0856 →
Continuity (1)
Related Publication 20150080226A1 · Mar 19, 2015